REG - Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma PharmaceuticalsAnnouncement

10/04/2018 14:35

RNS Number : 4612K
Hikma Pharmaceuticals Plc
10 April 2018
 

 
Hikma Pharmaceuticals PLC - EIP Awards
LONDON, 10 April 2018: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 10 April 2015 under the 2014 Executive Incentive Plan ("EIP") which was completed on

10 April 2018. These awards were automatically exercised by operation of the conditional award and vesting process. The exercise price under the EIP is £nil.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Bassam Kanaan




1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Bassam Kanaan




2


Reason for the notification




a)


Position/status


PDMR




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Shares acquired from vesting of the conditional awards on

10 April 2018 under the EIP.




c)


Price(s) and volume(s)


Price(s): £nil
Volume(s): 19,945




d)


Aggregated information


N/A




e)


Date of the transaction


10 April 2018




f)


Place of the transaction


London Stock Exchange (XLON)




 
Khalid Nabilsi




1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Khalid Nabilsi




2


Reason for the notification




a)


Position/status


PDMR




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Shares acquired from vesting of the conditional awards on

10 April 2018 under the EIP.




c)


Price(s) and volume(s)


Price(s): £nil
Volume(s): 14,165




d)


Aggregated information


N/A




e)


Date of the transaction


10 April 2018




f)


Place of the transaction


London Stock Exchange (XLON)




Riad Mishlawi




1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Riad Mishlawi




2


Reason for the notification




a)


Position/status


PDMR




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Shares acquired from vesting of the conditional awards on

10 April 2018 under the EIP.




c)


Price(s) and volume(s)


Price(s): £nil
Volume(s): 13,811




d)


Aggregated information


N/A




e)


Date of the transaction


10 April 2018




f)


Place of the transaction


London Stock Exchange (XLON)




 
 
Majda Labadi




1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Majda Labadi




2


Reason for the notification




a)


Position/status


PDMR




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Shares acquired from vesting of the conditional awards on

10 April 2018 under the EIP.




c)


Price(s) and volume(s)


Price(s): £nil
Volume(s): 10,089




d)


Aggregated information


N/A




e)


Date of the transaction


10 April 2018




f)


Place of the transaction


London Stock Exchange (XLON)




 
Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBXGDSXXBBGIG